Skip to main content
TipRanks
Go Ultimate75% OFF
ImpriMed Inc logo

ImpriMed Inc: Valuation, Funding & Investors

3980 Fabian Way Palo Alto, California 94303, UShttps://www.imprimedicine.com/Precision Medicine

ImpriMed, Inc. is a precision medicine company developing AI-driven drug response prediction technologies for cancer care. Its platform analyzes patient and tumor characteristics to help veterinarians and clinicians identify potentially effective treatments, reduce unnecessary costs, accelerate therapy decisions, and improve outcomes in canine, feline, and human oncology.

Leadership & Board

Current Number of Employees
45
Current LinkedIn Followers
5,907

Latest Estimated Valuation

Total Amount Raised
$10M
Total Funding Rounds
1
Latest Funding Amount
$10M
Latest Funding Round
Series A

Company Momentum

Positive
Articles Published on TipRanks2
LinkedIn Trend+0.12% followers
Workforce Trend+0.0% employees

ImpriMed Inc LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.

Employee Trend

ImpriMed Inc had 45 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.

45Latest Employee Count
0(0.00%)Week-Over-Week Change
020406080Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

ImpriMed Inc had 5,907 followers as of November 16, 2026. The number of followers increased by 7 (0.12%) week-over-week.

5,907Latest Followers Count
7(0.12%)Week-Over-Week Change
02,0004,0006,0008,000Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Sep 24, 2026Series A$10.00M―

Similar Companies

A snapshot of private companies similar to ImpriMed Inc, helping you discover and navigate related company profiles.

Related News and Analysis